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Introduction: Stem cells have the ability to self-renew or to differentiate into numerous cell types; however, our
understanding of how to control and exploit this potential is currently limited. An emerging hypothesis is that
microRNAs (miRNAs) play a central role in controlling stem cell-fate determination. Herein, we have characterized
the effects of miRNAs in differentiated human neural stem cells (hNSCs) by using a cell line currently being tested
in clinical trials for stroke disability (NCT01151124, Clinicaltrials.gov).
Methods: HNSCs were differentiated on 2- (2D) and 3-dimensional (3D) cultures for 1 and 3 weeks. Quantification of
hNSC differentiation was measured with real-time PCR and axon outgrowth. The miRNA PCR arrays were implemented
to investigate differential expression profiles in differentiated hNSCs. Evaluation of miRNA effects on hNSCs was
performed by using transfection of miRNA mimics, real-time PCR, Western blot, and immunocytochemistry.
Results: The 3D substrate promoted enhanced hNSC differentiation coupled with a loss of cell proliferation.
Differentiated hNSCs exhibited a similar miRNA profiling. However, in 3D samples, the degree and timing of
regulation were significantly different in miRNA members of cluster mi-R17 and miR-96-182, and hsa-miR-302a.
Overall, hNSC 3D cultures demonstrated differential regulation of miRNAs involved in hNSC stemness, cell
proliferation, and differentiation.
The miRNA mimic analysis of hsa-miR-146b-5p and hsa-miR-99a confirmed induction of lineage-committed
progenitors. Downregulated miRNAs were more abundant; those most significantly downregulated were selected,
and their putative target mRNAs analyzed with the aim of unraveling their functionality. In differentiated hNSCs,
downregulated hsa-miR-96 correlated with SOX5 upregulation of gene and protein expression; similar results
were obtained for hsa-miR-302a, hsa-miR-182, hsa-miR-7, hsa-miR-20a/b, and hsa-miR-17 and their target NR4A3.
Moreover, SOX5 was identified as a direct target gene of hsa-miR-96, and NR43A, a direct target of hsa-miR-7 and
hsa-mir-17 by luciferase reporter assays. Therefore, the regulatory role of these miRNAs may occur through
targeting NR4A3 and SOX5, both reported as modulators of cell-cycle progression and axon length.
Conclusions: The results provide new insight into the identification of specific miRNAs implicated in hNSC
differentiation. These strategies may be exploited to optimize in vitro hNSC differentiation potential for use in
preclinical studies and future clinical applications.Introduction
Stem cell research has the potential to support future
medical advances, especially in the unmet need for
chronic diseases [1]. Stem cells play central roles, both
in development of the organism and repair of damaged
tissue. CTX0E03 is a clonal conditionally immortalized* Correspondence: lara-stevanato@reneuron.com
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article, unless otherwise stated.human neural stem cell (hNSC) line [2]. This cell line has
defined quality characteristics that are required for cell
banking under good manufacturing practice (GMP), to
ensure reliable and reproducible stocks of cells suitable
for clinical application [3]. HNSCs can differentiate into
neurons, glia, and oligodendrocytes and have been shown
to ameliorate neurologic deficits in a rodent model of
focal ischemia after transplantation into the brain [2,4,5].
Recently this hNSC line was tested in a human clinicald Central Ltd. This is an Open Access article distributed under the terms of the
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(NCT01151124, Clinicaltrials.gov). Although the func-
tional properties of hNSCs have been studied extensively,
the molecular mechanisms underlying neural stem differ-
entiation are not fully understood.
MiRNAs have received emerging attention over the last
years as significant regulatory molecules [6]. They constitute
a subpopulation of small RNAs of average 22 nucleotides
in length. Unlike messenger RNAs (mRNAs), miRNAs do
not encode proteins, but rather bind 3′ untranslated re-
gion (3′ UTR) of mRNAs, regulating their stability and
translation into proteins. Functional studies indicate that
miRNAs participate in the regulation of a number of cellu-
lar processes, including development, proliferation, and
differentiation [7]. The discovery of miRNAs has offered
new potential for modulating stem cell lineage commit-
ment and differentiation by posttranscriptional gene
regulation [8,9]. Many studies have demonstrated that
transient overexpression or inhibition of brain-specific
miRNAs in stem cells significantly directed their differen-
tiation toward neuronal cell lineages [10]. Several miRNAs
have been implicated in regulating self-renewal of neural
stem cells and neuronal fate specification [11]. Herein we
compared miRNA profiling obtained from in vitro assays
of a clinical grade hNSC line to investigate further miRNA
functionality and effects on neuronal and glial differenti-
ation potential.
In two-dimensional (2D) standard differentiation proto-
cols, the complexity of the in vivo environment is not
reflected, and consequently, the induction and regulation
of hNSC differentiation is not optimal. In vivo, cells are
surrounded by other cells as well as many extracellular li-
gands, including many types of collagens, laminin, and
other matrix proteins (extracellular matrix, ECM) in a
three-dimensional (3D) microenvironment. Previous stud-
ies showed that specific topologic architecture of the
materials mimicking ECMs and their geometry influence
cell phenotype and fate [12-19]. A number of commer-
cially available 3D culture systems are available, including
Alvetex (Amsbio, UK). Alvetex is a highly porous polystyr-
ene scaffold engineered with a well-defined and uniform
architecture into a 200-μm-thick membrane, which pro-
vides a 3D space into which cells can invade and differenti-
ate [20]. The scaffold is formed by polymerization in a
biphasic emulsion, consisting of an aqueous and a nonaque-
ous monomer/surfactant phase, termed a high-internal-
phase emulsion, or HIPE [21,22]. The resulting polymer
(poly-HIPE) consists of a relatively homogeneous porous
network of voids, linked by interconnecting pores. More-
over, such scaffolds have been proven amenable for 3D
in vitro cell culture [20].
In the present study, 2D and 3D differentiation assays
were used to monitor mRNAs of neuronal and glial
markers and neurite outgrowth to identify miRNAsinvolved in the regulation of neuronal/glial differenti-
ation processes.
Material and methods
HNSC derivation, culture, and differentiation
CTX0E03 is a fully manufactured conditionally immortal-
ized hNSC line, originally derived from ethically sourced
human fetal brain cortical tissue of 12 weeks’ gestation and
described in [2]. To set up differentiation assays, a single-
cell suspension of hNSCs, obtained from passage 30 to 36
cell cultures, was achieved by trypsinization, and the num-
ber of cells determined by using a hemocytometer. Cells
were seeded either on standard cell-treated plastic vessels
(BD Biosciences) or on polystyrene scaffolds (Alvetex®,
Amsbio) in serum-free medium. Cells were maintained at
37°C in a humidified, 5% CO2 incubator for 1 and 3 weeks,
and cultured in the same defined medium without the mi-
togens, EGF, bFGF, and 4-OHT (Sigma).
Measurement of axon-process outgrowth
Measurement of axon-process outgrowth was performed
on differentiated and undifferentiated hNSCs fixed with
4% paraformaldehyde (PFA; Pioneer Research Chemicals)
and incubated with β3-tubulin (TUBB3) primary antibody
(Sigma). After rinsing, the cells were incubated with anti-
mouse Alexa Fluor 568 (Invitrogen) secondary antibody.
Cell nuclei were counterstained with Hoechst (Sigma, 1
μM). Measurement of axon-process length was carried
out on a minimum of three representative fields by using
Image-Pro Plus 7 software (Media Cybernetics).
Real-time RT-PCR (qRT-PCR) analysis of mRNA
HNSC total RNA was isolated by using miRNeasy (Qiagen),
according to the manufacturer’s protocol. A minimum of
250 ng of total RNA was reverse-transcribed into first-
strand cDNA by using a mix of random primer and poly-
dT. Reverse transcription was performed with superscript
II reverse transcriptase (Invitrogen) for 1 hour at 42°C,
inactivated for 15 minutes at 70°C, and cooled to 4°C. Two
microliters of cDNA were used in a PCR reaction contain-
ing 2× Roche master mix, 0.1 μg of human universal probe
library (UPL; Roche), and 0.4 μM primers for neuronal
markers: β3-tubulin (TUBB3), a well-established neuron-
specific marker expressed by neuronal precursors [23]; dou-
blecortin (DCX), a marker expressed in developing neu-
rons, and increasingly used as a marker for neurogenesis
[24]; microtubule-associated protein 2 (MAP2), involved in
microtubule assembly, which is an essential step in neuro-
genesis [25], and glial markers: glial fibrillary acidic protein
(GFAP), a well-recognized glia marker; S100 calcium-
binding protein B (S100B), a glia-specific marker expressed
primarily by astrocytes; and galactocerebroside (GALC),
expressed by differentiating oligodendrocyte precursor cells
[26]. The following primer sequences and UPL were used
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gggcgact, R) cgaggcacgtacttgtgaga, UPL 78; DCX (NM_
000555.2) F) gtggaggctggtaaagagca R) aggcccaagcataag
gaaat, UPL 6; MAP2 (NM_031845.2), F) cgaactttatatttt
accacttccttg, R) ccgttcatctgccattcttc, UPL 2; GFAP
(NM_002055.3) F) ccagttgcagtccttgacct, R) tctccaggg
actcgttcgt, UPL 88; S100B (NM_006272.2) F) cagg
atccttgcctccaac R) ctcagagcccccggtagt UPL 67; GALC
(NM_001037525.1), F) tggtgcctctttgcatatttta, R) atgtggg
agggctcagtg, UPL 9. QRT-PCR results were expressed
as relative quantification based on the 2-ΔΔct method
[27] and normalized against average of ATP5B and
YWHAZ (PrimerDesign) housekeeping genes. A mini-
mum of three biologic replicants was evaluated for each
marker and condition.
Measurement of cell proliferation
Measurement of cell proliferation was performed on dif-
ferentiated and undifferentiated hNSCs fixed with 4% PFA
and stained with Ki67 primary antibody, 1:100, (Thermo
Scientific). After rinsing, the cells were incubated at room
temperature with anti-rabbit Alexa Fluor 568 (Invitrogen)
secondary antibody. Cell nuclei were counterstained with
Hoechst (Sigma, 1 μM). A minimum of three representa-
tive fields was analyzed for each condition.
Stem cells and developmental pathways-focused miRNA
PCR-array analysis
The stem cells and developmental pathways-focused
miRNA PCR array (Qiagen, Sabiosciences) was carried
out according to manufacturer’s instructions. For each
array, a minimum of 250 ng total RNA was retrotran-
scribed by using miScript II RT Kit (Qiagen) according
to the manufacturer’s instruction. Each condition was
run in triplicate. Array analysis was performed by using
miScript miRNA PCR-array data analysis [28].
MiRNA mimic transfection
Before transfection, hNSCs were seeded into a 24-well
plate. MiRNA-transfection optimization was performed
by using allstars negative control siRNA AF 488 (Qia-
gen); by using the following condition, the miRNA trans-
fection efficiency was found to be 100%. Each of three
miRNA mimics (5 nM; Qiagen), hsa-miR-146b-5p, UG
AGAACUGAAUUCCAUAGGCU, hsa-miR-23b, AUCA
CAUUGCCAGGGAUUACC, and hsa-miR-99a, AACC
CGUAGAUCCGAUCUUGUG was combined with HiPer-
Fect (Qiagen) according to manufacturer’s instructions.
Control samples were transfected with green fluorescent
protein (GFP) plasmid. Samples were collected after 1
week. MiRNA-mimic cell internalization after transfection
was measured by qRT-PCR using miScript PCR Starter kit
(Qiagen) according to manufacturer’s instructions. Aminimum of three biologic replicants was evaluated for
each marker and condition.
Computational target gene predictions, validation by
real-time RT-PCR, and pathway analysis
DIANA-microT 3.0 algorithm [29,30] was used to identify
miRNA target prediction mRNA. In brief, the DIANA-
microT 3.0 algorithm consists of (a) alignment of the
miRNA driver sequence on the 3′ UTR of a protein-
coding gene, (b) identification of putative miRNA recogni-
tion elements score (MREs), based on specific binding
rules, (c) scoring of individual MREs according to their
binding type and conservation profile, (d) calculation of
an overall miRNA target gene (miTG) score through the
weighted sum of all MRE scores lying on the 3′ UTR. The
program is designed to use up to 27 different species to
estimate MRE conservation scores and combines both
conserved and nonconserved MREs in a final miTG score.
Similar analysis was conducted by using PicTar [31,32]
and TargetScan [33,34]. QRT-PCR was performed as
described by using the following primers: SRY (sex-
determining region Y)-box 5 (SOX5, NM_006940.4), F)
tttacctcaggagtttgaaagga, R) gcttgtcaccatggctacct, UPL 38;
forkhead box N3 (FOXN3, NM_005197.3) F) cattaagagg
tgtggcgttttt, R) gacacatgaaccgccactt, UPL 3; nuclear recep-
tor subfamily 4, group A, member 3 (NR4A3, NM_
173199) F) tctcagtgttggaatggtaaaaga, R) ggtttggaaggcagac-
gac, UPL 52; dual-specificity phosphatase 10 (DUSP10,
NM_007207.4) F) tgaatgtgcgagtccatagc R) tggcaattcaagaag
aactcaa UPL 22; translation initiation factor 4 gamma, 3
(EIF4G3, NM_003760.4) F) attctcaaaacttaaattcaagaagga,
R) tttcttccatgtctttggtacagt, UPL 33.
MiRNA KEGG pathway analysis of selected miRNAs
was performed by using DIANA LAB [30,35].
Western blot analysis
HNSC cell monolayers were lysed with 1× SDS sample buf-
fer and dithiothreitol (DTT) reducing agent (AMS Biotech-
nology), and loaded onto a PAGEgel (Invitrogen). After
electrophoresis, the proteins were blotted on nitrocellulose
membrane. Immunodetection was performed by using rabbit
anti-SOX5 and anti-Nor (NR4A3) polyclonal antibodies
(Santa Cruz Biotechnology Inc.) and detected by using a
horseradish peroxidase–conjugated anti-rabbit antibody (Cell
Signaling Technology). The nitrocellulose membrane was
then processed by using chemiluminescence-detection re-
agents (Thermo Scientific). The blots were stripped and
reprobed by using anti-α-tubulin (Sigma, 1:1,000) to act as
an internal loading-level standard. Western blot images were
captured by using BioRad FluorS Imaging.
Reporter plasmid transfection and dual luciferase assay
Transient transfections of HeLa cells were performed by
using Lipofectamine 2000 (Invitrogen) according to the
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were plated at a density of 105 cells/well in 24-well plates
and co-transfected with either 100 ng of MiTarget
MicroRNA 3′ UTR Target Clone HmiT019538-MT01
(GeneCopoeia, NR4A3 3′ UTR) or HmiT017632-MT01
(GeneCopoeia, SOX5 3′ UTR), as well as 20 nM miRNA
mimics (hsa-miR-96-5p for SOX5 3′ UTR, and hsa-miR-
7-5p, and hsa-miR-17-5p for NR4A3 3′ UTR, respectively)
per well. Control wells were transfected with either
HmiT019538-MT01 or HmiT017632-MT01 plasmid, and
allstars negative-control siRNA AF 488 (Qiagen). Trans-
fection efficiency was found to be 100%. HmiT019538-
MT0 and HmiT017632-MT01 plasmids express both
firefly and renilla luciferase. Firefly and renilla luciferase
activities were measured 24 hours after transfection by
using the Luc-Pair miR luciferase assay (GeneCopoeia)
and a GloMax 96 Microplate Luminometer (Promega).
Firefly luciferase activity was normalized to renilla lucifer-





























Figure 1 Quantification of hNSC differentiation. (A-E) Representative im
3-week (3W) 2D differentiated, (D) 1W 3D differentiated, and (E) 3W 3D dif
on 1W and 3W differentiated hNSCs cultured on 2D and 3D substrates. (G)
and glial (GALC, GFAP, and S100B) markers performed on hNSCs differentia
compared with undifferentiated control. Statistical analysis showed significa
point; ± SDMs. *P < 0.05; **P < 0.001, ***P < 0.005, Student t test.experiments, transfection and luciferase assays were per-
formed in triplicate.
Statistics
Data were analyzed by Student t test, and P < 0.05 was
considered statistically significant. All error bars indicate
± standard deviation of the mean (SDM). In stem cells
and developmental pathways focused miRNA PCR array
analysis, significant changes were defined as ±1.5-fold
up- and down-regulation to a statistically significant ex-
tent. A two-sample Student t test was used to analyze
each comparison.
Results
Quantification of differentiation by axon outgrowth and
real-time PCR molecular analysis, and quantification of
cell proliferation
Assessment of the ability of hNSCs to differentiate into
neurons, glia, and oligodendrocytes by immunocyto-100B GALC
F
C  
age of (A) undifferentiated, (B) 1 week (1W) 2D differentiated, (C)
ferentiated hNSCs; scale bar, 50 μm. (F) Quantification of axon length
QRT-PCR molecular analysis for neuronal (TUBB3, DCX, and MAP2)
ted on 2D and 3D for 1W, and 3W, and expressed as fold change
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Figure 2 Evaluation of hNSC proliferation. (A-E) Representative image of (A) undifferentiated, (B) 1W 2D differentiated, (C) 3W 2D
differentiated, (D) 1W 3D differentiated, and (E) 3W 3D differentiated hNSCs stained with Ki67, marker of cell proliferation; scale bar, 50 μm; Ki67+
hNSCs (red), nuclear Hoechst counterstain (blue). (F) Quantification of cell proliferation measured as percentage of cells positive for Ki67.
Statistical analysis showed a significant reduction in proliferation in 2D and 3D cultures compared with the proliferative control and between 2D











































Figure 3 Human cell differentiation and development miScript
miRNA PCR array profiles. Group clustergram analysis of miRNA
PCR array profiles analysis of differentially regulated miRNAs
identified in control (undifferentiated hNSCs) and hNSCs seeded
on 2D and 3D substrates and differentiated for 1W and 3W.
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present study, quantification of hNSC differentiation
was performed by measuring axon outgrowth and
neural/glial marker transcript expression. Axon out-
growth (Figure 1A through E) was significantly enhanced
in 3D cultures (195.76 μm± 9.36, and 258.22 μm ±
18.55) compared with traditional flat-surface cultures
(2D) (59.33 μm± 7.00, and 95.12 μm± 7.15) evaluated
at 1- (1W) and 3- (3W) week differentiation, respect-
ively (Figure 1F). GALC, GFAP, TUBB3, S100B, DCX,
and MAP2 mRNA expression-level analysis showed a
significant increase in all the tested markers in 3D
1W compared with 2D 1W differentiated cultures.
Furthermore, TUBB3 and GFAP were significantly en-
hanced in 3D compared with 2D differentiated cul-
tures at the 3-week time point (Figure 1G).
The expression of Ki67, a cellular marker for prolifera-
tion [36] (Figure 2A through E), was measured in prolif-
erative hNSC (control) and after differentiation for 1W
and 3W on both 2D and 3D cultures. A significant de-
crease in Ki67 staining was observed in all differentiated
samples. The percentage of Ki67 positive cells signifi-
cantly dropped from 52.28 ± 2.03 in control samples to
32.09 ± 3.96, (1W), 20.59 ± 0.50 (3W) in 2D, and 3.52 ±
0.49 (1W) and 2.86 ± 0.50 (3W) in 3D differentiated cul-
tures (Figure 2F).
Human cell differentiation and development miScript
miRNA PCR array profiles
Stem cells and developmental pathways focused miRNA
PCR array (Sabioscience; Qiagen) was implemented to
investigate miRNAs differential expression profiles after
hNSC 2D and 3D differentiation for 1W and 3W.The geo-mean of SNORD61, SNORD68, SNORD72,
SNORD95, SNORD96A, and RNU6-2 was used for data
analysis based on the 2-ΔΔct methods. Significant changes
were defined as ±1.5-fold up- and downregulation
compared with control, undifferentiated/proliferative
cultures.
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PCR array. Hsa-miR-146b-5p, hsa-miR-99a-5p, and
the hsa-let-7 family (hsa-let-7c, and 7b), and hsa-
miR-23b were identified as significantly upregulated
in both 2D and 3D differentiated samples (Figure 3,
Table 1). The let-7 family [37] and hsa-miR-23b [38]
are known posttranscriptionally to regulate neural
cell specification. Interestingly, hsa-miR-99a and hsa-
miR-146b-5p, reported to be related to the immune
system and cancer inhibition [39,40], have not yet
been correlated with neuronal or glial differentiation.
The miRNA profiling identified several significantly
down-regulated miRNAs: to facilitate data interpret-
ation they were grouped by functionality (Table 2),
time, and type of culture substrate. MiRNAsTable 1 Statistical analysis performed on miRNA PCR arrays
P-values (compared with control group)
Mature ID 2D (1W) 3D (1W) 2D (3W) 3D (3W
hsa-miR-302a-3p ✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-10a-5p NS NS ✶✶✶ ✶✶✶
hsa-miR-10b-5p NS ✶ ✶✶✶ ✶✶✶
hsa-miR-96-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-183-5p ✶✶✶ ✶✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-182-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-7-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-17-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-18a-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-20a-5p ✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-20b-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-93-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-106b-5p ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-15a-5p NS NS ✶✶✶ ✶
hsa-miR-15b-5p NS NS ✶✶✶ ✶✶✶
hsa-miR-16-5p NS NS ✶✶✶ ✶✶
hsa-miR-195-5p NS ✶ ✶✶✶ ✶✶
hsa-miR-21-5p ✶ NS NS ✶✶
hsa-miR-33a-5p NS NS ✶✶✶ ✶✶
hsa-miR-128 NS NS ✶ ✶
hsa-miR-424-5p NS NS ✶✶ ✶✶✶
hsa-miR-130a-3p NS ✶✶ ✶✶✶ ✶
hsa-miR-345 ✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-let-7b ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-let-7c ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-146b-5p ✶✶✶ ✶ ✶✶✶ ✶✶✶
hsa-miR-23b ✶✶✶ ✶✶✶ ✶✶✶ ✶✶✶
hsa-miR-99a ✶✶✶ ✶✶✶ ✶✶✶ ✶
Data were analyzed with Student t test, ✶ P < 0.05, ✶✶P < 0.001, ✶✶✶ P < 0.005, andassociated with maintenance and regulation of pluri-
potency, neuronal lineage specification and differen-
tiation [41] and those acting on proteins associated
with cell cycle regulation, proliferation, and stem cell
renewal [42-46] were identified (Table 2). Time de-
pendency downregulation was observed. Hsa-miR-
302a, cluster miR-17-92, and miR-96-182, from 1W,
and miR-15 family from 3W were respectively
significantly downregulated (Figure 3, Table 1). Sig-
nificant differences comparing 2D and 3D sub-
strate types were observed at both time points in
miRNAs belonging to cluster miR-17-92 [46] and
miR-96-182 [47] (regulators of cell proliferation), and
hsa-miR-302a (maintenance of stemness), (Figure 3,
Table 1).P values (compared with 2D versus 3D)
































Table 2 Functions of downregulated miRNAs































































































Figure 4 MiRNA mimic transfection analysis. A) hsa-miR-146b-5p, hsa-m
RT-PCR, and expressed as fold change compared with GFP transfected hNS
and MAP2) and glial (GALC, GFAP, and S100B) markers of 146b-5p, hsa-miR
change compared with GFP transfected hNSCs (control). Statistical analysis
**p < 0.001, ***p < 0.005, Student’s t-test.
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of neuronal and glial gene markers
Based on array analysis we selected three up-regulated
miRNAs to substantiate their effects on neuronal/glial
differentiation. Hsa-miR-99a, hsa-miR-146b-5p, and hsa-
miR-23b mimics were transfected into hNSCs. Quantifi-
cation of each miRNA mimic up-take and expression of
GALC, GFAP, TUBB3, S100B, DCX, and MAP2 mRNAs
were measured by qRT-PCR. All selected mimic miRNAs
were appropriately transfected and quantified in hNSCs
(Figure 4A) and they significantly increased GFAP, DCX,
and MAP2 markers when compared to control. In con-
trast significant increases in gene expression of the oligo-
dendrocyte precursor marker GALC and the astrocytic
glial marker S100B were solely induced by hsa-miR-99a,
whereas the neuronal precursor marker TUBB3 was solely
induced by hsa-miR-146b-5p (Figure 4B).
MiRNA target prediction analysis, validated by real-time
RT-PCR, dual luciferase reporter assay, and miRNA KEGG
pathway analysis using the DIANA Lab algorithms
Top ranking down-regulated miRNAs were selected to
identify predicted miRNA target mRNAs by using the
online tool, DIANA-microT 3.0. Although this analysis
is constrained in terms of predictive ability, it is the only
tool available for putative miRNA targets, and the out-
put is useful for predicting hypothetical connections be-
tween miRNAs, targeted pathways, and biological
functions. Since different algorithms often yield different
results, the resulting putative target mRNAs were also
checked with other similar online available algorithms:




iR-23b, hsa-miR-99a transfected mimics were measured by real-time
Cs (control). B) QRT-PCR molecular analysis for neuronal (TUBB3, DCX,
-23b, hsa-miR-99a mimic transfected hNSCs and expressed as fold
was performed against transfected control; ± SDMs, *p < 0.05,
Table 3 Computational target gene predictions
DIANALAB microT v3.0 PicTar TargetScan
miRNA Target gene Rank miTG score Precision SNR Target sites/genes found Score Aggregate PCT
hsa-miR-96 SOX5 2 64.73 1 7.3 1214/763 6.74 0.94
hsa-miR-183 DUSP10 1 26.44 0.72 1.62 302/190 4.75 0.85
hsa-miR-302a NR4A3 27 19.86 0.84 6.22 863/473 3.05 NF
hsa-miR-182 FOXN3 3 37.4 0.94 6.87 1358/794 NF 0.96
hsa-miR-7 NR4A3 NF NF NF NF NF 1.61 0.17
hsa-miR-7 FOXN3 7 14.08 0.17 1.03 399/136 NF 0.88
hsa-miR-20a NR4A3 9 26.13 0.85 9.44 1650/841 5.87 0.63
hsa-miR-20b NR4A3 11 25.60 0.9 9 1955/973 5.87 0.63
hsa-miR-17 NR4A3 13 25.85 0.9 7.94 1928/961 5.38 0.63 + 0.37
hsa-miR-20a EIF4G3 3 55.29 0.97 9.44 1650/841 NF NF
hsa-miR-20b EIF4G3 1 46.9 0.94 8 1955/973 NF NF
hsa-miR-17 EIF4G3 1 46.87 0.94 7.94 1928/961 NF NF
List of miRNA target-prediction mRNAs. MiRNAs, and target-predictive genes were identified by algorithms analysis by using Diana Lab, PicTar, and TargetScan.
Scores (aggregate) are provided for each analysis.
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973 to 302/190 total target sites per gene identified. To
overcome this issue we only investigated top ranked
miRNA target genes that were previously referenced to
brain development and function or were target sites of
multiple investigated miRNAs. Validation of predicted tar-
gets was performed by qRT-PCR. SOX5, NR4A3 (NOR1),
and FOXN3 were found to be significantly up-regulated in
differentiated samples compared with control. In addition
DUSP10 was only found to be up- regulated in 3D differ-
entiated cultures at 3W. Among the putative target
mRNAs, only EIF4G3 was not up-regulated and therefore
did not correlate with the prediction (Figure 5A). To sup-
port miRNA target prediction we also examined protein
expression of SOX5 and NR4A3.
We performed Western blot analysis for two of the
predictive target mRNA, SOX5, and NR4A3 (NOR1).
The differential expression of these proteins was verified
in 2D and 3D differentiated hNSCs at both time points
(1W and 3W) and compared with proliferative controls
(Figure 5B).
Computational analysis of SOX5 3′-UTR with Tar-
getScan revealed three putative binding sites for hsa-
miR-96, located at nucleotides 347–375, 693–721, and
1,677–1,705, respectively. Same analysis of NR4A3 3′-
UTR revealed three putative binding sites for hsa-miR-7
located at nucleotides 490–518, 568–596, and 2,612–
2,640, and for hsa-miR-17, located at nucleotides 262–
290, 1,556–1,584, and 1,688–1,716, respectively. To
study the direct interaction between the miRNAs and
their putative site on the 3′-UTR we used two commer-
cially available plasmids containing either SOX5 or
NR4A3 3′-UTR inserted downstream of the firefly
luciferase reporter gene, and renilla luciferase gene fornormalization. In HeLa cells transiently transfected with
the SOX5 3′-UTR, and NR4A3 3′-UTR constructs and
selected mimic miRNAs or miRNA control, a significant
inhibition of luciferase activity was observed. Hsa-miR-
96 caused a decrease in SOX5 3′-UTR luciferase activity
by 60.34% ± 4.79%, and both hsa-miR-7 and hsa-miR-17
caused a decrease in NR4A3 3′-UTR luciferase activity
by 65.01% ± 4.07% and 45.11% ± 6.76, respectively, com-
pared with controls (Figure 5C).
Top-ranked downregulated miRNAs: hsa-miR-96, hsa-
miR-182, hsa-miR-183, hsa-miR-7 and hsa-miR-302a were
analyzed by using the DIANA-microT 4.0 algorithm to in-
vestigate the KEGG pathway. Axon guidance exhibited the
highest union combined score (Figure 5D). This result
mirrored axon-outgrowth measurements (Figure 2F).
Discussion
Highly orchestrated programs of gene expression act to
shape the developing nervous system. More recently,
it has become clear that gene expression can also be mod-
ulated by several classes of small RNAs. In this study, we
profiled miRNA differential expression patterns in hNSCs
differentiated in 2D and 3D culture systems. HNSC differ-
entiation was assessed by measuring processes/axons out-
growth and gene expression of well-established neural and
glial markers. MiRNA profile of 2D versus 3D was very
similar in terms of miRNA types; but the degree and tim-
ing of miRNA differential regulation was significantly
different for miRNAs involved in both maintenance of
stemness (hsa-miR-302a), and cell proliferation (the clus-
ters miR-17-92 and miR-96-183). The upregulated miR-
NAs: hsa-miR-146b-5p, hsa-miR-23b, and hsa-miR-99a
were selected, and their mimics were transfected into





















































































































Figure 5 Validation of miRNA target-predicted genes. (A) qRT-PCR analysis performed on 1W and 3W differentiated hNSCs cultured on 2D
and 3D substrates and expressed as fold change compared with proliferative control. Statistical analysis showed significant difference compared
with control; ±SDMs, *P < 0.05, **P < 0.001, ***P < 0.005, Student t test. (B) SOX5 and NR4A3 protein quantification performed by Western blot on
1W and 3W differentiated hNSCs cultured on both 2D or 3D substrates and proliferative control. (C) Dual luciferase report assay. Measurement of
the relative luciferase activity of SOX5 and NR4A3 3′-UTR constructs transfected with hsa-miR-96, and hsa-miR-7 and 17, respectively. Data are
expressed as mean values ± SDMs and are shown as percentage of control (cells transfected with either SOX5 or NR4A3 3′-UTR constructs and
control microRNA). Each bar represents values from three independent experiments, measured in triplicate. The relative activity of firefly luciferase
expression was normalized to renilla luciferase activity. Data were analyzed with Student t test, ***P < 0.005. (D) MiRNA KEGG pathway analysis
results obtained by using DIANA Lab.
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http://stemcellres.com/content/5/2/49progenitors into neurons or glia. GALC and S100B gene
expression was significantly upregulated after transfection
of hsa-miR-99a mimics, suggesting a role in promoting
differentiation of hNSC into glial restricted progenitors
and oligodendrocyte progenitor cells. Similarly, hsa-miR-
146b-5p transfection promoted upregulation of TUBB3
gene expression. Taken together, hsa-miR-99a and hsa-
miR-146b-5p appear to be involved in early-stage commit-
ment of glial and neuronal precursors, respectively.
The most significantly downregulated miRNAs were
selected and analyzed to assess their putative targetmRNAs with the intent of determining their functional-
ity and identifying KEGG pathway maps for biological
interpretation. By using online-available software ana-
lysis tools (DIANA Lab, PicTar, and TargetScans), we
identified and verified a set of target mRNAs correlated
with selected downregulated miRNAs. A single miRNA
can recognize hundreds of targets. However, several
miRNAs can target one gene. NR4A3, a target of the
hsa-miR-7, hsa-miR302a, and miR-17 family, is a mem-
ber of the NR4A family of nuclear receptors, which, de-
pending on their level of expression, are involved in the
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http://stemcellres.com/content/5/2/49differentiation, survival, apoptosis, and regulation of hip-
pocampal axon guidance [50]. Similarly, SOX5, a target
of hsa-miR-96, is reported to control cell-cycle progres-
sion in neural progenitors [51], axon length [52], migra-
tion, postmigratory differentiation, and projections of
neurons [53]. NR4A3 and SOX5 were selected as pos-
sible candidate regulators of cell-cycle progression and
axonal regulation.
QRT-PCR and Western blot analysis confirmed upreg-
ulation of both NR4A3 and SOX5. Furthermore, SOX5
and NR4A3 were identified as direct target genes of hsa-
miR-96, and hsa-miR-7 and 17, respectively, by luciferase
reporter assays. These findings, together with miRNA
KEGG pathway analysis, support a possible regulatory
role of these identified miRNAs as cellular regulators of
axon guidance and outgrowth regulation. By mimicking
a tissue-like environment, 3D scaffolds may enhance en-
vironmental guidance cues that modulate miRNA ex-
pression to promote axon outgrowth.
Conclusions
Overall, 3D hNSC culture was associated with greater
arrest of cell proliferation, increased incidence of differ-
entiation, and differential degree and timing of regula-
tion in miRNA expression compared with 2D systems.
These observations suggest that 3D surface topography
influences hNSC molecular behavior by modulating
miRNAs associated with cell proliferation and stemness
maintenance, thereby promoting cell differentiation.
Additionally, 3D architecture may provide contact guid-
ance that could regulate miRNAs involved in developmen-
tal processes, including growing axons and neuritogenesis.
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